Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03219502 : Repetitive Transcranial Magnetic Stimulation (rTMS) for Neuropathy
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Patients with stage I-III colorectal cancer who received oxaliplatin chemotherapy

2. Understand and read English, sign a written informed consent, and be willing to follow
protocol requirements

3. ECOG Performance Status of 0-2

4. Grade 2 or higher neuropathic pain according to the National Cancer Institute's 4
point grading scale

5. Neuropathic symptoms must be related to chemotherapy (in the opinion of the treating
physician)

6. Patients must have neuropathic symptoms for a minimum of 3 months

7. No plans to change the type of pain medication (if a patient is on pain medication)

8. Willing to come to MD Anderson for the therapy sessions

9. Off active chemotherapy for a minimum of 3 months as documented by their medical
record

10. Patients who are 18 years of age or above

Exclusion Criteria:

1. Patients who are taking any antipsychotic medications

2. Patients who have evidence of brain metastases or any with any active central nervous
system (CNS) disease at their time of entry into the trial

3. Patients who have ever been diagnosed with bipolar disorder or schizophrenia

4. Patients who have a history of head injury, focal brain lesions, or known seizure
activity

5. Patients who are withdrawing from drugs

6. Patients with intracranial implants or a cardiac pacemaker or any device that is not
considered MRI safe. Colorectal patients are sometimes prescribed Tramadol to help
control the symptoms of CIPN. Tramadol does lower the seizure threshold, however these
patients will be considered eligible for the study if they discontinue the drug 48
hours before the baseline and do not use it during the duration of the study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03219502      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740